Angiotensin II inhibition increases cellular glucose transport during reperfusion but not ischemia in pig hearts

Scandinavian Cardiovascular Journal

Volumn 37, Issue 4, 2003, Pages 205-210

  Randsbæk, Flemming ^a   Lund, Steen ^a   Kimose, Hans Henrik ^a   Grove, Erik ^a   Bøtker, Hans Erik ^a   Schmitz, Ole ^a   Toftegaard Neilsen, Torsten ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLGLUCOSE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BENAZEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; RENIN; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; EXPOSURE; FEMALE; GLUCOSE TRANSPORT; GLUCOSE TRANSPORT SYSTEM; HEART BEAT; HEART MUSCLE; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PACING; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; INHIBITION KINETICS; ISCHEMIC HEART DISEASE; MALE; MODULATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SAMPLING; STIMULUS RESPONSE; SWINE; TIME;

ADENOSINE TRIPHOSPHATE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CARDIAC PACING, ARTIFICIAL; CELL MEMBRANE; DISEASE MODELS, ANIMAL; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN; HEART RATE; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MODELS, CARDIOVASCULAR; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIUM; RENIN; SWINE; SYSTOLE; TIME FACTORS;

EID: 0042380049     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430310002040     Document Type: Article

References (16)

1. The Heart Outcome Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145-153.
2. Rett K, Maeker E, Renn W, van Gielst W, Haering HE. Perfusion-independent effect of bradykinin and fosinoprilate on glucose transport in Langendorff rat hearts. Am J Cardiol 1997; 80: 143A-147A.
3. Hoenack C, Roesen P. Inhibition of angiotensin type 1 receptor prevents decline of glucose transporter (GLUT4) in diabetic rat heart. Diabetes 1996; 45: S82-S87.
4. Randsbæk F, Kimose HH, Hansen SB, Jacobsen B, Bøtker HE, Nielsen TT. Captopril improves oxygen and glucose extraction in pig hearts during reperfusion after cold cardioplegic storage. Scand Cardiovasc J 2000; 34: 201-208.
5. Jagadeesh G. Angiotensin II receptor-antagonists, molecular biology, and signal transduction. Indian J Exp Biol 1998; 36: 1171-1194.
6. Bøtker HE, Møller N, Schmitz O, Bagger JP, Nielsen TT. Myocardial insulin resistance in patients with syndrome X. J Clin Invest 1997; 100: 1919-1927.
7. Randsbæk F, Kimose HH, Bjerre T, Møldrup U, Bøtker HE, Nielsen TT. Captopril induced glutamate release at start of reperfusion after cold cardioplegic storage of pig hearts. J Thorac Cardiovasc Surg 2000; 119: 1030-1038.
8. Buhl ES, Jessen N, Schmitz O, et al. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside increases insulin stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber-type specific manner. Diabetes 2001; 50: 12-17.
9. Bøtker HE, Helligsø P, Kimose HH, Thomassen AR, Nielsen TT. Determination of high energy phosphates and glycogen in cardiac and skeletal muscle biopsies, with special reference to influence of biopsy technique and delayed freezing. Cardiovasc Res 1994; 28: 524-527.
10. Nielsen AH, Gotfredsen P, Nielsen PB, Hyttel P, Poulsen K. Measurement of renin and prorenin in cattle, hog and horse. Comp Biochem Physiol A 1991; 100: 127-131.
11. Holtz J, Busse R, Sommer O, Bassenge E. Dilation of epicardial arteries in conscious dogs induced by angiotensin-converting enzyme inhibition with enalaprilat. J Cardiovasc Pharmacol 1987; 9: 248-255.
12. Tada H, Thompson CI, Recchia FA, et al. Myocardial glucose uptake is regulated by nitric oxide via endothelial nitric oxide synthase in Langendorff mouse heart. Circ Res 2000; 86: 270-274.
13. Kishi K, Muromoto N, Nakaya Y, et al. Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes 1998; 47: 550-558.
14. Morales C, Rodriguez M, Scapin O, Gelpi RJ. Comparison of the effects of ACE inhibition with those of angiotensin II receptor antagonism on systolic and diastolic myocardial stunning in isolated rabbit heart. Mol Cell Biochem 1998; 186: 117-121.
15. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and micro vascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE sub study. Lancet 2000; 355: 253-259.
16. Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999; 353: 611-616.